According to reports from Business Standard, Kerala Ayurveda reported a consolidated net loss of ₹7.98 crore in the quarter ended June 2026, marking a significant deterioration from the net profit of ₹1.99 crore recorded during the corresponding quarter of the previous financial year. The company's financial performance showed contrasting trends across key metrics during the first quarter of FY27.
As reported by Business Standard, the company's sales revenue increased by 16.01% to ₹33.19 crore in Q1 FY27, compared to ₹28.61 crore in the same quarter of the previous financial year. This revenue growth indicates the company's ability to expand its business operations despite the overall financial challenges faced during the quarter.
According to the financial data reported by Business Standard, the company's operating profit margin (OPM) improved to -11.54% in Q1 FY27 from -14.61% in the corresponding quarter of the previous year. However, the company reported a PBDT loss of ₹6.36 crore compared to a PBDT profit of ₹4.46 crore in Q1 FY26, indicating challenges in maintaining profitability at the pre-tax level.
As reported by Business Standard, the company's PBT (Profit Before Tax) turned negative at ₹8.23 crore in Q1 FY27, compared to a PBT profit of ₹2.81 crore in the same quarter of the previous year. The net loss of ₹7.98 crore in Q1 FY27 represents a significant increase from the net profit of ₹1.99 crore recorded in Q1 FY26, highlighting the company's operational challenges during the quarter.
